台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效

中化生

(1762)
可現股當沖
  • 股價
    46.20
  • 漲跌
    ▼0.05
  • 漲幅
    -0.11%
  • 成交量
    59
  • 產業
    上市 生技醫療類股
  • 250人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中化生 (1762)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/28     後一日»

券商獲利排行 - 2024/03/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  7.56%234.50.2234.4-611625049.95046.2
  7.71%77.1077.1-2002050.1050.146.2
  7.60%76076-1902050505046.2
  7.97%40040-1001050.2050.246.2
  7.78%39039-1001050.1050.146.2
  7.34%32.9032.9-80949.950.149.946.2
  7.51%22.5022.5-6065005046.2
  7.51%22.5022.5-6065005046.2
  7.46%22.4022.4-50649.95049.946.2
  7.82%19.6019.6-50550.1050.146.2
  2.09%18.7018.7-4131849.949.949.946.2
  7.36%18.3018.3-50549.9049.946.2
  7.78%15.6015.6-40450.1050.146.2
  7.69%15.4015.4-40450.1050.146.2
  7.65%15.3015.3-4045005046.2
  7.60%15.2015.2-30450505046.2
  7.37%14.7014.7-40449.9049.946.2
  7.60%11.4011.4-3035005046.2
  7.51%11.2011.2-3035005046.2
  7.32%10.9010.9-30349.9049.946.2
  7.97%808-20250.2050.246.2
  7.78%7.807.8-20250.1050.146.2
  7.78%7.807.8-20250.1050.146.2
  7.78%7.807.8-20250.1050.146.2
  7.69%7.707.7-20250.1050.146.2
  7.60%7.607.6-2025005046.2
  7.60%7.607.6-2025005046.2
  7.60%7.607.6-2025005046.2
  7.60%7.607.6-2025005046.2
  7.60%7.607.6-2025005046.2
  7.60%7.607.6-2025005046.2
  7.60%7.607.6-2025005046.2
  7.51%7.507.5-2025005046.2
  7.41%7.407.4-20249.9049.946.2
  7.41%7.407.4-20249.9049.946.2
  7.32%7.307.3-20249.9049.946.2
  7.97%404-10150.2050.246.2
  7.97%404-10150.2050.246.2
  7.97%404-10150.2050.246.2
  3.99%40.13.9-11250.15050.146.2
  7.97%404-10150.2050.246.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.9-10150.1050.146.2
  7.78%3.903.900150.150.150.146.2
  7.78%3.903.9-10150.1050.146.2

券商虧損排行 - 2024/03/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.62%-106.70-106.728280505050.146.2
  -5.14%-100.3-0.8-99.526391350505046.2
  -7.56%-94.50-94.5252505050046.2
  -7.63%-840-84222205050046.2
  -7.60%-760-76202005050046.2
  -7.54%-640-64171705050046.2
  -7.24%-57.9-0.1-57.91516150.150.15046.2
  -7.55%-56.60-56.6151505050046.2
  -7.54%-56.50-56.5151505050046.2
  -7.60%-380-38101005050046.2
  -7.03%-35.2-0.1-35.1910150.150.15046.2
  -7.60%-22.80-22.86605050046.2
  -7.51%-150-15340505050.146.2
  -7.37%-14.70-14.744049.949.9046.2
  -0.80%-13.1-5.3-7.92333150.150.15046.2
  -7.60%-11.40-11.43305050046.2
  -7.60%-11.40-11.43305050046.2
  -7.60%-11.40-11.43305050046.2
  -7.78%-7.80-7.822050.150.1046.2
  -7.60%-7.60-7.62205050046.2
  -7.55%-7.50-7.52205050046.2
  -7.41%-7.40-7.422049.949.9046.2
  -7.41%-7.40-7.412049.949.950.146.2
  -7.32%-7.30-7.322049.949.9046.2
  -2.00%-4-0.1-3.904350.150.150.146.2
  -7.97%-40-411050.250.2046.2
  -7.78%-3.90-3.911050.150.1046.2
  -7.60%-3.80-3.81105050046.2
  -7.60%-3.80-3.81105050046.2
  -7.60%-3.80-3.801050505046.2
  -7.60%-3.80-3.81105050046.2
  -7.60%-3.80-3.81105050046.2
  -7.60%-3.80-3.801050505046.2
  -7.60%-3.80-3.81105050046.2
  -7.60%-3.80-3.81105050046.2
  -7.51%-3.70-3.71105050046.2
  -7.41%-3.70-3.711049.949.9046.2
  -7.41%-3.70-3.711049.949.9046.2
  -7.41%-3.70-3.711049.949.9046.2
  -7.41%-3.70-3.711049.949.9046.2
  -7.33%-3.70-3.711049.949.9046.2
  -7.32%-3.70-3.711049.949.9046.2
  -7.32%-3.60-3.611049.949.9046.2
  -7.32%-3.60-3.611049.949.9046.2
  -7.32%-3.60-3.601049.949.950.146.2
  -7.32%-3.60-3.611049.949.9046.2
  -7.32%-3.60-3.611049.949.9046.2
  -7.32%-3.60-3.611049.949.9046.2
  -7.32%-3.60-3.611049.949.9046.2
  -0.20%-0.1-0.1001150.150.15046.2
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章